Lack of interaction between systemic lupus erythematosus-associated polymorphisms in TYK2 and IRF5

Journal of Rheumatology

Volumn 37, Issue 3, 2010, Pages 676-677

  Suarez Gestal, Marian ^a   Calaza, Manuel ^a   Gonzalez, Antonio ^a  

^a Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 5; PROTEIN KINASE TYK2;

CONTROLLED STUDY; GENE INTERACTION; GENETIC EPISTASIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

CASE-CONTROL STUDIES; EPISTASIS, GENETIC; GENOTYPE; HUMANS; INTERFERON REGULATORY FACTORS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TYK2 KINASE;

EID: 77949747046     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090823     Document Type: Letter

References (10)

1. Rhodes B, Vyse TJ. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology 2008;47:1603-11.
2. Hellquist A, Järvinen TM, Koskenmies S, Zucchelli M, Orsmark-Pietras C, Berglind L, et al. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. J Rheumatol 2009;36:1631-8.
3. Suarez-Gestal M, Calaza M, Endreffy E, Pullmann R, Ordi-Ros J, Domenico Sebastiani G, et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009;11:R69.
4. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006;25:745-55.
5. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40:204-10.
6. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
7. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappa-B pathways. Nat Genet 2009;41:199-204.
8. Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, Sebastiani GD, et al. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun 2007;8:429-38.
9. North BV, Curtis D, Sham PC. Application of logistic regression to case-control association studies involving two causative loci. Hum Hered 2005;59:79-87.
10. Kozyrev SV, Lewén S, Reddy PM, Pons-Estel B, Argentine Collaborative Group, Witte T, et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 2007;56:1234-41.